Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methods used to assess clinical outcome and quality of life in osteoarthritis.
Fioravanti A, Cantarini L, Fabbroni M, Righeschi K, Marcolongo R. Fioravanti A, et al. Among authors: fabbroni m. Semin Arthritis Rheum. 2005 Jun;34(6 Suppl 2):70-2. doi: 10.1016/j.semarthrit.2004.03.017. Semin Arthritis Rheum. 2005. PMID: 16206962 Review. No abstract available.
Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort.
Cantarini L, Fabbroni M, Talarico R, Costa L, Caso F, Cuneo GL, Frediani B, Faralli G, Vitale A, Brizi MG, Sabadini L, Galeazzi M. Cantarini L, et al. Among authors: fabbroni m. Medicine (Baltimore). 2015 Jul;94(30):e1170. doi: 10.1097/MD.0000000000001170. Medicine (Baltimore). 2015. PMID: 26222847 Free PMC article.
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseasesResponse to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677-1683.
Gentileschi S, Barreca C, Bellisai F, Biasi G, Brizi MG, De Stefano R, Fabbroni M, Fioravanti A, Frati E, Selvi E, Vitale A, Cantarini L, Frediani B, Galeazzi M. Gentileschi S, et al. Among authors: fabbroni m. Expert Opin Biol Ther. 2016 Oct;16(10):1311-2. doi: 10.1080/14712598.2016.1198765. Epub 2016 Jun 28. Expert Opin Biol Ther. 2016. PMID: 27266338 No abstract available.
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study.
Giannitti C, Lopalco G, Vitale A, Rigante D, Anelli MG, Fabbroni M, Manganelli S, Galeazzi M, Frediani B, Barone M, Lapadula G, Iannone F, Cantarini L. Giannitti C, et al. Among authors: fabbroni m. Clin Exp Rheumatol. 2017 Jan-Feb;35(1):93-97. Epub 2016 Dec 9. Clin Exp Rheumatol. 2017. PMID: 27974094
22 results